ResMed Inc. (RMD)

ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, and residential care software the remainder. Growth depends on diagnosing more of the large untreated sleep apnea population and moving them onto therapy. The Americas contribute about two-thirds of device and mask revenue, with most of the rest from Europe, Japan, and Australia.

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)

Market region: US

Address: 9001 Spectrum Center Blvd., San Diego, CA, 92123

Market capitalization

32.34 billion USD (32,342,686,906 USD)

Listing date

06/02/1995

Weighted shares outstanding

140,657,071

Share class shares outstanding

140,639,243

https://www.resmed.com